A follow-up study utilizing interviews and survey responses demonstrates that patients prefer rhenium-188 skin cancer therapy (RSCT) over surgery in the treatment of their non-melanoma skin cancer.
And despite her high-risk of developing skin cancer from the ultraviolet rays, the 18-year-old student refuses to forgo her faux glow. “I want to stop one day but I can’t ever imagine myself not going ...